RSCM
RYTM icon

Rock Springs Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$54.4M Buy
861,153
+26,965
+3% +$1.7M 3.39% 4
2025
Q1
$44.2M Sell
834,188
-328,530
-28% -$17.4M 2.53% 11
2024
Q4
$65.1M Sell
1,162,718
-65,375
-5% -$3.66M 2.48% 10
2024
Q3
$64.3M Sell
1,228,093
-52,400
-4% -$2.75M 2.09% 11
2024
Q2
$52.6M Sell
1,280,493
-242,400
-16% -$9.95M 1.58% 21
2024
Q1
$66M Hold
1,522,893
1.68% 19
2023
Q4
$70M Sell
1,522,893
-74,230
-5% -$3.41M 1.72% 20
2023
Q3
$36.6M Hold
1,597,123
0.98% 33
2023
Q2
$26.3M Hold
1,597,123
0.63% 52
2023
Q1
$28.5M Sell
1,597,123
-163,742
-9% -$2.92M 0.68% 49
2022
Q4
$51.3M Hold
1,760,865
1.23% 30
2022
Q3
$43.1M Buy
1,760,865
+357,567
+25% +$8.76M 1.11% 30
2022
Q2
$5.82M Buy
1,403,298
+166,272
+13% +$690K 0.17% 94
2022
Q1
$14.3M Buy
1,237,026
+609,846
+97% +$7.03M 0.36% 73
2021
Q4
$6.26M Buy
627,180
+15,000
+2% +$150K 0.14% 112
2021
Q3
$8M Buy
612,180
+5,900
+1% +$77.1K 0.17% 116
2021
Q2
$11.9M Buy
606,280
+7,000
+1% +$137K 0.23% 104
2021
Q1
$12.7M Buy
599,280
+108,941
+22% +$2.32M 0.28% 95
2020
Q4
$14.6M Buy
490,339
+26,253
+6% +$781K 0.31% 92
2020
Q3
$10.1M Sell
464,086
-48,025
-9% -$1.04M 0.26% 102
2020
Q2
$11.4M Buy
512,111
+12,111
+2% +$270K 0.31% 97
2020
Q1
$7.61M Buy
500,000
+155,000
+45% +$2.36M 0.31% 85
2019
Q4
$7.92M Buy
345,000
+40,000
+13% +$918K 0.25% 92
2019
Q3
$6.59M Buy
305,000
+70,000
+30% +$1.51M 0.26% 91
2019
Q2
$5.17M Buy
235,000
+18,500
+9% +$407K 0.19% 100
2019
Q1
$5.93M Hold
216,500
0.23% 101
2018
Q4
$5.82M Buy
216,500
+1,500
+0.7% +$40.3K 0.27% 92
2018
Q3
$6.27M Hold
215,000
0.23% 104
2018
Q2
$6.72M Buy
215,000
+143,500
+201% +$4.49M 0.26% 107
2018
Q1
$1.42M Hold
71,500
0.06% 140
2017
Q4
$2.08M Buy
+71,500
New +$2.08M 0.09% 130